Healthways, Inc. (NASDAQ:TVTY) has been given a consensus recommendation of “Buy” by the ten research firms that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $43.14.

TVTY has been the subject of a number of analyst reports. Zacks Investment Research upgraded Healthways from a “sell” rating to a “hold” rating in a research note on Wednesday, September 6th. Chardan Capital initiated coverage on Healthways in a research note on Tuesday, August 29th. They set a “neutral” rating and a $40.00 price objective for the company. ValuEngine cut Healthways from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Jefferies Group LLC restated a “buy” rating and set a $46.00 price objective on shares of Healthways in a research note on Monday, September 25th. Finally, Barrington Research upped their price objective on Healthways from $35.00 to $44.00 and gave the stock an “outperform” rating in a research note on Friday, July 28th.

In other Healthways news, insider Glenn Hargreaves sold 7,137 shares of the stock in a transaction dated Tuesday, September 26th. The stock was sold at an average price of $40.00, for a total value of $285,480.00. Following the completion of the sale, the insider now directly owns 52,180 shares in the company, valued at $2,087,200. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Mary Flipse sold 1,340 shares of the stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $37.32, for a total value of $50,008.80. Following the completion of the sale, the insider now owns 75,187 shares of the company’s stock, valued at $2,805,978.84. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,824,858 shares of company stock valued at $69,172,017. 8.42% of the stock is currently owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC raised its stake in Healthways by 158.7% in the second quarter. Lord Abbett & CO. LLC now owns 745,372 shares of the company’s stock valued at $29,704,000 after buying an additional 457,285 shares during the last quarter. Piedmont Investment Advisors LLC purchased a new stake in Healthways in the second quarter valued at about $290,000. Flinton Capital Management LLC raised its stake in Healthways by 63.5% in the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock valued at $139,000 after buying an additional 1,360 shares during the last quarter. Riverhead Capital Management LLC raised its stake in Healthways by 69.7% in the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock valued at $142,000 after buying an additional 1,464 shares during the last quarter. Finally, Eaton Vance Management purchased a new stake in Healthways in the second quarter valued at about $625,000.

Shares of Healthways (TVTY) traded up 0.061% during trading on Wednesday, hitting $40.775. The stock had a trading volume of 225,254 shares. Healthways has a 12 month low of $19.25 and a 12 month high of $43.00. The stock has a 50-day moving average price of $39.56 and a 200 day moving average price of $36.38. The company has a market cap of $1.61 billion, a P/E ratio of 18.367 and a beta of 0.38.

Healthways (NASDAQ:TVTY) last issued its quarterly earnings data on Thursday, July 27th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.03. The firm had revenue of $138.90 million during the quarter, compared to analysts’ expectations of $138.15 million. Healthways had a return on equity of 29.81% and a net margin of 17.30%. Healthways’s revenue for the quarter was up 11.1% compared to the same quarter last year. Equities analysts expect that Healthways will post $1.53 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Healthways, Inc. (TVTY) Receives Average Rating of “Buy” from Analysts” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/18/healthways-inc-tvty-receives-average-rating-of-buy-from-analysts.html.

Healthways Company Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Analyst Recommendations for Healthways (NASDAQ:TVTY)

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.